Not all cancer patients need chemo — Ataraxis AI raised $20M to personalize treatment
The New York-based startup is focused on using AI to accurately predict not only if a patient has cancer, but also what their ...
Ataraxis AI to Transform Precision Medicine in Cancer Care with $20.4 Million Series A
Ataraxis AI, the leading AI precision medicine company, today announced its $20.4 million Series A financing led by AIX ...
Le Lézard21h
In light of the recent PGT-A class action lawsuit filings in a court in Florida, Vitrolife Group issues the following statement
Vitrolife Group is aware that a PGT-A class action lawsuit has been filed against Vitrolife AB (publ), Vitrolife Inc and Igenomix USA, Inc in the court of the Southern District of Florida, although no ...
Le Lézard20h
Planful Elevates Customer Service with New Innovations to Drive Even Faster Resolutions and Greater Efficiency
Planful Inc., the pioneer of financial performance management cloud software, has made strategic investments designed to enhance the customer experience and further strengthen its award-winning ...
Precision Medicine Online19h
Precision Medicine Startup Ataraxis AI Nabs $20.4M in Series Financing
Ataraxis AI will use the new funding to bring to market its first offering, Ataraxis Breast, an AI-native prognostic/predictive platform for breast cancer.